• Exchange: -
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Fresenius Kabi Oncology Ltd


Ticker Delisted

Snapshot for Fresenius Kabi Oncology Ltd (FKOL)

Open: - Day's Range: - Volume: 0
Previous Close: - 52wk Range: - 1-Yr Rtn: -

Stock Chart for FKOL

No chart data available.
  • FKOL:IN 132.50
  • 1M
  • 1Y
Interactive FKOL Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for FKOL

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SENSEX -
Earnings Per Share (ttm) 1.0117
Est. EPS -
Est. PEG Ratio -
Market Cap (M INR) 0.00
Shares Outstanding (M) 158.23
30 Day Average Volume -
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend (INR) -
Dividend Ex-Date 06/29/2009
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for FKOL

No data available

Company Profile & Key Executives for FKOL

Fresenius Kabi Oncology Ltd. manufactures oncology drugs. The Company produces oral and injectable cancer drugs, and active pharmaceutical ingredients.

Peter F NilssonManaging Director/CEORakesh SharmaExec VP:Human Resources
Satish B KulkarniExec VP:South East AsiaKamal Jeet GuptaExec VP:API Business
More Company Profile & Key Executives for FKOL

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil